The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...

(Reuters) -Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after ...

By Julie Steenhuysen CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good ...

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

BUT BEFORE I LET YOU GO, ONE LAST QUESTION ABOUT VACCINE. AND THIS IS COVID. SO, YOU KNOW, WE’VE TALKED ABOUT THAT AT NAUSEUM FOR THE LAST, WHAT, FIVE YEARS. PROTECTION WANES OVER TIME.

There, Marks oversaw the critical process of reviewing and approving vaccines—like those against COVID-19—and biologic therapies, including gene- and cell-based treatments. Marks earned trust ...

By a year later, 66 million American adults had gotten at least one dose of a COVID-19 vaccine, at no cost to them. Now, a new study shows how wise that national investment in testing, buying and ...

The flu vaccine is recommended annually for all Americans 6 months and older, per the Centers for Disease Control and Prevention — but a new study from Cleveland Clinic suggests that it might ...

He said DOD this week has begun to send letters of apology to former service members who were involuntarily separated due to their COVID-19 vaccine status, along with instructions on how they can ...

Get Instant Summarized Text (Gist) The U.S. investment in COVID-19 vaccines proved economically beneficial, saving more in avoided medical costs than the expenditure on the vaccine effort. The ...